Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Equillium, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +2 vs. Q2 2024
- Shares held
- 8.72M
- −131.5K (−1.5%) vs. Q2 2024
- Total value
- $7.25M
- +$1.12M (+18.3%) vs. Q2 2024
- New holders
- 7
- 3 more added
- Sold out
- 5
- 4 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $133.0M |
| Q1 2026 | 50 | $81.0M |
| Q4 2025 | 36 | $54.7M |
| Q3 2025 | 40 | $42.4M |
| Q2 2025 | 27 | $2.74M |
| Q1 2025 | 24 | $3.39M |
| Q4 2024 | 26 | $6.52M |
| Q3 2024 | 26 | $7.25M |
| Q2 2024 | 25 | $6.15M |
| Q1 2024 | 28 | $20.5M |
| Q4 2023 | 25 | $6.85M |
| Q3 2023 | 25 | $6.75M |
| Q2 2023 | 27 | $7.44M |
| Q1 2023 | 28 | $7.86M |
| Q4 2022 | 31 | $13.3M |
| Q3 2022 | 30 | $28.4M |
| Q2 2022 | 25 | $25.6M |
| Q1 2022 | 30 | $39.7M |
| Q4 2021 | 26 | $27.0M |
| Q3 2021 | 22 | $49.9M |
| Q2 2021 | 28 | $41.9M |
| Q1 2021 | 33 | $54.6M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Equillium, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Decheng Capital LLC | 4,447,308 | $3.70M | 0.88% | 00.0% | Unchanged |
| Takeda Pharmaceutical Co Ltd | 1,824,977 | $1.51M | 3.99% | 00.0% | Unchanged |
| Vanguard Group Inc | 841,948 | $700.5K | 0.00% | 00.0% | Unchanged |
| Cota Capital Management, LLC | 562,278 | $467.8K | 1.87% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 321,173 | $267.2K | 0.00% | +20,773+6.9% | Added |
| Geode Capital Management, LLC | 204,385 | $170.1K | 0.00% | −11,819−5.5% | Reduced |
| Acadian Asset Management LLC | 108,691 | $89.0K | 0.00% | 00.0% | Unchanged |
| Callan Capital, LLC | 99,688 | $82.9K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 59,720 | $49.7K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 40,165 | $33.4K | 0.00% | +40,165 | New |
| Northern Trust Corp | 35,019 | $29.1K | 0.00% | 00.0% | Unchanged |
| DCF Advisers, LLC | 32,962 | $27.4K | 0.01% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 25,000 | $21.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 19,351 | $16.1K | 0.00% | +13,064+207.8% | Added |
| HRT Financial LP | 18,064 | $15.0K | 0.00% | −12,442−40.8% | Reduced |
| GWM Advisors LLC | 17,700 | $14.7K | 0.00% | +17,700 | New |
| Two Sigma Securities, LLC | 17,494 | $14.6K | 0.00% | +17,494 | New |
| XTX Topco Ltd | 16,955 | $14.1K | 0.00% | +16,955 | New |
| Virtu Financial LLC | 14,152 | $12.0K | 0.00% | +14,152 | New |
| ADAR1 Capital Management, LLC | 7,318 | $6.09K | 0.00% | −133,457−94.8% | Reduced |
| Lazard Asset Management LLC | 1,594 | $1.00K | 0.00% | +1,594 | New |
| Wells Fargo & Company | 1,000 | $832 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 467 | $388 | 0.00% | +309+195.6% | Added |
| Barclays PLC | 104 | $87 | 0.00% | +104 | New |
| JPMorgan Chase & Co | 43 | $36 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 169 | $0 | 0.00% | −8,902−98.1% | Reduced |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −43,504−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Tritonpoint Wealth, LLC | 0 | $0 | 0.00% | −13,500−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −10,119−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |